Growth Insights for CEOs

Why MedTech’s Brilliant Innovators Must Also Become Commercial Architects
| Great technology is necessary. It is not sufficient. The graveyard of MedTech is lined with brilliant innovations that never found their market — not because of scientific failure, but commercial invisibility. |
I just returned from LSI USA ‘26 in Dana Point — the most impressive gathering of emerging MedTech talent I’ve witnessed in decades. The event convened 2,000 executives, 394 presenting startups, and over 500 active investors and strategics. The scientific ambition in that room was extraordinary.
Recent Posts

Why CPG Companies Will Have to Innovate or...
Wed, Nov 29, 2023 — Challenger brands have nearly doubled the innovation success rate vs. leading brands By: Mike Concannon and Evan Eckman Which business author is famous for the quote “innovate or die”? Peter Drucker, Tom Peters, or Dr. Jack Matson? Answer: All of the above. It was a fundamental business principle for the past century. So why has the collective wisdom of these contemporary business authors seemingly been forgotten by the big CPG companies this century?